ClinicalTrials.govpublic full text
A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
breast cancer, postmenopausal, metastatic phase i only, azd0530 (saracatinib), anastrozole, phase i for metastatic disease, phase ii for newly diagnosed breast cancer, pharmacokinetic, pk, hormone receptor, estrogen receptor, progesterone receptor
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 802605
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.